ATR - AptarGroup, Inc.
NEXT EARNINGS:
May 7, 2026
EPS Est: $1.16
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$169.67
DETAILS
HIGH:
$220.00
LOW:
$133.00
MEDIAN:
$156.00
CONSENSUS:
$169.67
UPSIDE:
17.71%
Market Cap:
9.46B
Volume:
353,909
Avg Volume:
541,798
52 Week Range:
103.23-164.28
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.48
Last Dividend:
$1.86
Exchange:
NYSE
Country:
US
Employees:
13,000
IPO Date:
1993-04-23
EPS (TTM):
5.97
P/E Ratio:
20.41
Revenue (TTM):
3.78B
Total Assets:
5.25B
Total Debt:
1.53B
Cash & Equiv:
402.42M
Rev Growth (5Y):
5.2%
EPS Growth (5Y):
12.5%
FCF Growth (5Y):
-1.2%
ROCE:
13.3%
Debt/Equity:
0.57
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $1.25 | $1.24 | +0.8% | $962.7M | $923.7M | +4.2% |
| 2025-10-30 | $1.62 | $1.57 | +3.2% | $961.1M | $880.2M | +9.2% |
| 2025-07-31 | $1.66 | $1.58 | +5.1% | $966.0M | $959.0M | +0.7% |
| 2025-05-01 | $1.20 | $1.16 | +3.4% | $887.3M | $898.6M | -1.3% |
| 2025-02-06 | $1.52 | $1.28 | +18.8% | $848.1M | $852.3M | -0.5% |
| 2024-10-24 | $1.49 | $1.42 | +4.9% | $909.3M | $862.0M | +5.5% |
| 2024-07-25 | $1.37 | $1.36 | +0.7% | $910.1M | $933.2M | -2.5% |
| 2024-04-25 | $1.26 | $1.15 | +9.6% | $915.4M | $931.5M | -1.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.78B | 3.58B | 3.49B | 3.32B | 3.23B | 2.93B | 2.86B | 2.76B | 2.47B | 2.33B | 2.32B | 2.60B |
| Net Income | 392.79M | 374.54M | 284.49M | 239.29M | 244.10M | 214.04M | 242.20M | 194.75M | 220.03M | 205.59M | 199.35M | 191.66M |
| EPS | 5.97 | 5.65 | 4.34 | 3.66 | 3.72 | 3.32 | 3.81 | 3.12 | 3.52 | 3.27 | 3.19 | 2.95 |
| Total Assets | 5.25B | 4.43B | 4.45B | 4.20B | 4.14B | 3.99B | 3.56B | 3.38B | 3.14B | 2.61B | 2.44B | 2.44B |
| Total Debt | 1.53B | 1.08B | 1.18B | 1.22B | 1.24B | 1.23B | 1.25B | 1.29B | 1.26B | 948.10M | 819.44M | 843.29M |
| Cash & Equivalents | 402.42M | 223.84M | 223.64M | 141.73M | 122.92M | 300.14M | 241.97M | 261.82M | 712.64M | 466.29M | 489.90M | 399.76M |
| Operating Cash Flow | 570.00M | 643.41M | 575.24M | 478.62M | 363.44M | 570.15M | 514.46M | 313.63M | 324.73M | 325.30M | 323.76M | 316.33M |
| Free Cash Flow | 299.58M | 349.22M | 256.84M | 163.00M | 55.51M | 318.11M | 267.38M | 101.77M | 168.10M | 193.82M | 174.44M | 154.38M |
| FCF per Share | 4.56 | 5.26 | 3.91 | 2.49 | 0.85 | 4.94 | 4.21 | 1.63 | 2.69 | 3.09 | 2.79 | 2.37 |
| Book Value | 2.67B | 2.47B | 2.31B | 2.05B | 1.97B | 1.85B | 1.57B | 1.42B | 1.31B | 1.17B | 1.15B | 1.10B |
| Cash & ST Investments | 409.53M | 226.18M | 223.64M | 141.73M | 123.67M | 300.38M | 241.97M | 261.82M | 712.64M | 466.29M | 519.72M | 399.76M |
| ROC Equity | 0.15 | 0.15 | 0.12 | 0.12 | 0.12 | 0.12 | 0.15 | 0.14 | 0.17 | 0.18 | 0.17 | 0.17 |